A Brief Guide to Endocannabinoid Signaling

Neurotransmission is a complex and highly orchestrated process within the brain, where communication between neurons occurs through the release and reception of chemical messengers. While traditional neurotransmitters typically act in a unidirectional manner from presynaptic to postsynaptic neurons, endocannabinoids introduce a unique twist to this narrative. They act on postsynaptic neurons and function as regulators;  thereby influencing the release of neurotransmitters and modulating their impact on neurons. This article briefly discusses endocannabinoid signaling, shedding light on its mechanisms and the interaction with exogenous cannabinoids found in the cannabis plant.

What is Neurotransmission?

Neurotransmission is the fundamental process through which information is conveyed between neurons. The sequence of events in neurotransmission unfolds as follows: First, a message initiates its journey from the dendrites, traversing the cell body and traveling down the length of the axon. Subsequently, this message prompts the release of chemicals known as neurotransmitters from the end of the axon into the synapse—the junction between the axon of one neuron and the dendrites of another. Acting as messengers, neurotransmitters carry the information across this synaptic gap.

The synapse serves as a crucial space where communication between neurons occurs. Upon reaching the synapse, neurotransmitters travel to specialized locations on the dendrites of the recipient neuron, binding to receptors in a manner akin to keys fitting into locks. Once this binding occurs, the message is successfully conveyed to the second neuron. Finally, the neurotransmitters detach from the receptors, and they are either broken down or reabsorbed into the axon of the initial neuron, completing the intricate cycle of neurotransmission. This finely tuned process ensures the swift and precise transmission of information within the neural network.

What is Endocannabinoid Neurotransmission?

Cannabinoid receptors, primarily CB1 and CB2, serve as the docking points for endocannabinoids. CB1 receptors are densely expressed in the central nervous system, regulating functions such as cardiovascular activity, reproduction, pain, and cognition. On the other hand, CB2 receptors are mainly situated in the periphery, modulating inflammation and immune responses. Vanilloid receptors, like transient receptor potential vanilloid (TRPV)-1, also contribute to endocannabinoid signaling, influencing neuronal transmission in a non-retrograde manner.

The endocannabinoid system (ECS) involves not only receptors but also biosynthetic and degradative enzymes, such as fatty acid amidohydrolase and monoacylglycerol lipase, which play a crucial role in regulating the effects of endocannabinoids on various physiological processes.

Unlike their counterparts, endocannabinoids like anandamide (AEA) and 2-arachidonylglycerol (2-AG) are synthesized in postsynaptic neurons, acting as neuromodulators that regulate the release of neurotransmitters through retrograde signaling. This process involves feedback from postsynaptic to presynaptic neurons, influencing short- and long-term plasticity. The endocannabinoids interact with cannabinoid receptors, particularly CB1 and CB2, which are part of the larger endocannabinoid system. This intricate dance between endocannabinoids and receptors, along with the involvement of vanilloid receptors and regulatory enzymes, forms a sophisticated network that fine-tunes neurotransmission, impacting various physiological functions.

Endocannabinoid Affinities and Activity

Anandamide (AEA), often referred to as the “bliss molecule,” is a high-affinity, partial agonist of CB1 receptors. This means that it tightly binds to CB1 receptors, enhancing their activity with a lower efficacy compared to full agonists. AEA has minimal activity, if any, at CB2 receptors. In contrast, 2-AG is a full agonist at both CB1 and CB2 receptors, exhibiting moderate to low affinity. AEA also acts as a full agonist of the TRPV1 receptor, contributing to its role in the ECS.

Endocannabinoids are synthesized within postsynaptic neurons on demand, triggered by calcium influx. This on-demand production allows for precise regulation of their effects on neurotransmission.

Phytocannabinoid Signaling

The cannabis plant contains hundreds of compounds, but delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) stand out as the major cannabinoids. When consumed, these phytocannabinoids interact with the innate ECS, mimicking the actions of endocannabinoid signaling.

THC, the psychoactive component of cannabis, is a partial agonist of both CB1 and CB2 receptors, with a high affinity for CB1 receptors, contributing to its intoxicating effects. On the other hand, CBD exhibits a low binding affinity to both receptors. Instead, it influences other neurotransmitter systems, including serotonin, peroxisome proliferator-activated receptors, and TRPV1 receptors. CBD also acts as a noncompetitive negative allosteric modulator at the CB1 receptor, mitigating some of the effects of THC, such as anxiety and tachycardia.

Conclusion

Endocannabinoid signaling plays a crucial role in modulating neurotransmission, maintaining homeostasis in various physiological processes. Understanding the intricate dance between endocannabinoids and their receptors provides insights not only into the functioning of the ECS but also into the potential therapeutic applications of cannabinoids. As research in this field progresses, a deeper understanding of endocannabinoid signaling may unlock new avenues for the treatment of various neurological and physiological disorders.